Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Asset Utilization Ratio (2022 - 2025)

Atara Biotherapeutics' Asset Utilization Ratio history spans 4 years, with the latest figure at 4.79 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 367.94% year-over-year to 4.79; the TTM value through Dec 2025 reached 4.79, up 367.94%, while the annual FY2025 figure was 1.87, 98.87% up from the prior year.
  • Asset Utilization Ratio reached 4.79 in Q4 2025 per ATRA's latest filing, up from 4.53 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 4.79 in Q4 2025 to a low of 0.02 in Q3 2023.
  • Average Asset Utilization Ratio over 4 years is 1.41, with a median of 0.44 recorded in 2024.
  • Peak YoY movement for Asset Utilization Ratio: plummeted 73.53% in 2023, then surged 4063.3% in 2024.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.17 in 2022, then tumbled by 73.53% to 0.05 in 2023, then soared by 2166.62% to 1.02 in 2024, then skyrocketed by 367.94% to 4.79 in 2025.
  • Per Business Quant, the three most recent readings for ATRA's Asset Utilization Ratio are 4.79 (Q4 2025), 4.53 (Q3 2025), and 3.81 (Q2 2025).